South Korea Anti-Obesity Drug Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets

The South Korea Anti-Obesity Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global South Korea Anti-Obesity Drug market. This report explores all the key factors affecting the growth of the global South Korea Anti-Obesity Drug market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141676/

The South Korea anti-obesity drugs market size stood at around USD 118.9 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of around xx% during the forecast period.

Obesity is a medical condition in which excess body fat get saturated into human body to the level that it may have adverse impact on health. Anti-obesity drugs contain certain pharmacological ingredient intended to reduce or control weight. Regulation of body weight is controlled by the brain cells which uses a variety of neuropeptides and transmitters and are responsive to endocrine and metabolic signals. Targeting these cells with novel pharmaceutical drugs is the basic way of controlling obesity. Medically anti-obesity drugs are prescribed only in cases of morbid obesity, where weight loss is lifesaving.

According to 2019 Obesity Fact Sheet released by the Korean Society for Study of Obesity, from 2009 to 2018, the prevalence of obesity and abdominal obesity increased to 35.7% and 23.8% respectively.

Market Drivers

Obesity rates in Korea are among the lowest in the OECD but have been increasing steadily. About 4% of the adult population is obese in Korea, and about 30% are overweight (including obese). OECD projections indicate that overweight rates will increase by a further 5% within ten years. This increase in the obesity population is expected to drive the demand for anti-obesity drugs in the near future. Changing lifestyle, decrease in exercise practice, consumption of cholesterol rich and packed food are some of the other potential market drivers.

Side effects such as the risk of psychiatric disorder, stroke is expected to impact the market growth over the forecast period negatively.

To Know More About COVID-19 Impact On South Korea Anti-Obesity Drug Market @ https://www.prudentmarkets.com/sample-request/141676/

Market Segmentation

By Mechanism of Action:

On the basis of mechanism of action anti-obesity market is segmented into incretin mimetics/GLP-1 agonists, SNDRIs, lipase inhibitors, serotonin receptor agonists, sympathomimetic-GABA receptor agonists, sympathomimetics and others.

By Target Site:

According to the target site market is segmented into peripherally acting and centrally acting drugs.

By Therapy Type:

Monotherapy and polytherapy are the market segments based on the type of therapy.

By Distribution Channel:

According to distribution channel market is segmented into hospitals, clinics, and pharmacies.

Top Players

Leading the expansion of the obesity treatment market in 2019 and 2020 were Novo Nordisk's Saxenda and Alvogen Korea's Qushimia. Saxenda's sales were worth USD 32.8 million in 2020. Although it decreased by 13.6% compared to the previous year, the sales volume is the largest among obesity treatment drugs in the market. Its market share based on accumulated sales last year was 25.7%. Some of the other major players in market Daewoong, Huons, Chong Kun Dang, Kwang Dong, Daehan New Pharm, Hanmi, Ahngook.

Highlighted Segments of South Korea Anti-Obesity Drug Market:

Industry Overview: The first section of the research study covers an overview of the global South Korea Anti-Obesity Drug Market, market status and prospects, and product range. In addition, it provides highlights of the major segments of the global Market, i.e., region, type, and application segments.

Competitive Analysis: This report illuminates important mergers and acquisitions, business expansion, product or service differences, market concentration, the competitive status of the global South Korea Anti-Obesity Drug Market, and market size by player.

Company Profiles and Key Data: This section covers companies profiling the major players in the global South Korea Anti-Obesity Drug Market based on the aforementioned revenue, products, business, and other factors.

Market size by type and application: In addition to providing an in-depth analysis of the industry size by type and application, this section provides research on top end users or consumers and potential applications.

Market Dynamics: This report covers the drivers, trends, and opportunities of the global South Korea Anti-Obesity Drug Market. This section also includes Porter's analysis of five forces.

Findings and Conclusions: It provides strong recommendations for new as well as established players for securing a position of strength in the global South Korea Anti-Obesity Drug Market.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141676/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global South Korea Anti-Obesity Drug Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global South Korea Anti-Obesity Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the South Korea Anti-Obesity Drug market
Chapter 2: Exclusive Summary - the basic information of the South Korea Anti-Obesity Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the South Korea Anti-Obesity Drug
Chapter 4: Presenting the South Korea Anti-Obesity Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the South Korea Anti-Obesity Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Why should you purchase this report?

-Prudent Markets provides the vital historical and analysis data of global South Korea Anti-Obesity Drug market.
-The report provides the entire assessment of the future market and altering market scenario or behavior.
-All the business decision could be backed through the several strategic business methodologies offered in the report.
-An extra edge in the competitive market could be obtained from this elaborative research report
-The report offers all the competitive landscape, growth drivers, applications, market dynamics, and other necessary details as well.

Purchase this report (Single User License) @ https://www.prudentmarkets.com/checkout/?id=141676&license_type=su

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the South Korea Anti-Obesity Drug Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.